skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
BCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024
BCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

BCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024

PR Newswire, 2024

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
2
Pasteur Institute of Iran Reports Findings in Vaccines
Pasteur Institute of Iran Reports Findings in Vaccines
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Pasteur Institute of Iran Reports Findings in Vaccines

Journal of Engineering, 2023, p.2344

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
4
Codagenix Receives Additional Award from US Department of Defense to Advance Development of Dengue Vaccine
Codagenix Receives Additional Award from US Department of Defense to Advance Development of Dengue Vaccine
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Receives Additional Award from US Department of Defense to Advance Development of Dengue Vaccine

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
5
Codagenix Announces Late-Breaking Presentation of Positive Clinical Immunogenicity Data For COVID-19 Vaccine Candidate CoviLiv™ at IDWeek 2023
Codagenix Announces Late-Breaking Presentation of Positive Clinical Immunogenicity Data For COVID-19 Vaccine Candidate CoviLiv™ at IDWeek 2023
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Announces Late-Breaking Presentation of Positive Clinical Immunogenicity Data For COVID-19 Vaccine Candidate CoviLiv™ at IDWeek 2023

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
6
Codagenix Announces BARDA Contract for Project NextGen Supporting Development of CoviLiv™ as an Intranasal COVID-19 Vaccine
Codagenix Announces BARDA Contract for Project NextGen Supporting Development of CoviLiv™ as an Intranasal COVID-19 Vaccine
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Announces BARDA Contract for Project NextGen Supporting Development of CoviLiv™ as an Intranasal COVID-19 Vaccine

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
7
Codagenix Initiates Dosing in Phase 1 Study of Intranasal, Live-Attenuated RSV Vaccine, CodaVax™- RSV, in a Pediatric Population
Codagenix Initiates Dosing in Phase 1 Study of Intranasal, Live-Attenuated RSV Vaccine, CodaVax™- RSV, in a Pediatric Population
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Initiates Dosing in Phase 1 Study of Intranasal, Live-Attenuated RSV Vaccine, CodaVax™- RSV, in a Pediatric Population

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
8
Codagenix Announces Appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officer
Codagenix Announces Appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officer
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Announces Appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officer

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
9
Primordial Genetics Launches High-Performance RNA Polymerases
Primordial Genetics Launches High-Performance RNA Polymerases
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Primordial Genetics Launches High-Performance RNA Polymerases

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
10
Codagenix Announces Close of $25 million Extension of Series B
Codagenix Announces Close of $25 million Extension of Series B
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Codagenix Announces Close of $25 million Extension of Series B

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (30)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.